Replies to post #5773 on Revance Therapeutics Inc (RVNC)

[Emannow]

I believe Allergan had offered $200 million in cash for OPUL, and OPUL elected to take the RVNC 8.5 million shares now worth $50 million.

Maybe Foley will sell to Allergan for 1.2 million shares of Abbive. The AbbVie shares could be the most valuable asset for RVNC! 🤣. Let’s see if Foley continues his streak of bad decisions.